Target Populations in Allogeneic Hematopoietic Cell Transplantation for Autoimmune Diseases— A Workshop Accompanying: Cellular Therapy for Treatment of Autoimmune Diseases, Basic Science and Clinical Studies, Including New Developments in Hematopoietic and Mesenchymal Stem Cell Therapy11Sponsored by the Bernie Marcus Foundation and the City of Hope National Medical Center, in Collaboration with NIAID, NCI, EULAR, and EBMT; Newport Beach, California; October 7, 2005
Open Access
- 1 June 2006
- journal article
- other
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (6) , 688-690
- https://doi.org/10.1016/j.bbmt.2006.02.007
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Feasibility of Allogeneic Hematopoietic Stem Cell Transplantation for Autoimmune Disease: Position Statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute–Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005Transplantation and Cellular Therapy, 2005
- Age-dependent incidence, time course, and consequences of thymic renewal in adultsJournal of Clinical Investigation, 2005
- Stem cell transplantation for aplastic anemia and myelodysplastic syndromeBone Marrow Transplantation, 2005
- Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donorsBlood, 2004
- In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR β-CDR3 sequencingThe Lancet, 2004